GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: compound 1 [WO2022017494]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Socrodeucitinib is the INN for a (deuterated) Janus kinase inhibitor with anti-inflammatory potential (included in WHO INN proposed list 133, 10th July 2025). The structure is claimed as compound 1 in patent WO2022017494A1 (Hansoh Biopharmaceutical), and is proposed as a TYK2 inhibitor [1]. Hansoh have TYK2 inhibitor HS-10374 in phase 2 and 3 clinical trials for psoriatic arthritis and psoriasis, but we are unable to confirm a name-to-structure match at this time (July 2025).
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
IUPAC Name ![]()  | 
                                                        
| 6-(cyclopropanecarbonylamino)-4-[3-(1-cyclopropyl-1,2,4-triazol-3-yl)-2-methoxyanilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 13300 | socrodeucitinib | 
Synonyms ![]()  | 
                                                        
| compound 1 [WO2022017494] | 
Database Links ![]()  | 
                                                        |
| CAS Registry No. | 2457365-35-2 (source: WHO INN record) | 
| GtoPdb PubChem SID | 518520694 | 
| PubChem CID | 157020998 | 
| Search Google for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N | 
| Search Google for chemicals with the same backbone | ZERZXBOGPOPJMF | 
| Search PubMed clinical trials | socrodeucitinib | 
| Search PubMed titles | socrodeucitinib | 
| Search PubMed titles/abstracts | socrodeucitinib | 
| UniChem Compound Search for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | ZERZXBOGPOPJMF-FIBGUPNXSA-N |